CX-1026

N/A

Report date: 2023/09/20 09:18:37
NME

Base Information

Drug NameCX-1026
Drug Alias NameCX-1026CX1026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase inhibitorsHistone deacetylase 6 inhibitorsVascular endothelial growth factor receptor 2 antagonists
TargetsAXL receptor tyrosine kinaseHistone deacetylase 6Vascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Konruns Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Konruns Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A